Jia-Xin Lin, Qing Zhou, Hong-Hong Yan, Qian Chu, Guowu Wu, Anwen Liu, Jiuwei Cui, Ying Liu, Haipeng Xu, Yingying Du, Yi Yang, HaiYan Tu, Yi-Long Wu, Si-Yang Maggie Liu. "Implementing flexible and adapted follow-up strategies in a patient-centric, phase II trial of first-line lorlatinib for advanced ALK-positive non–small cell lung cancer (CTONG2203).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e13545